Articles

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
Niguarda Ca’ Granda Hospital, Milano, Italy
1st Department of Internal Medicine, University of Athens, Laikon General Hospital, Athens, Greece
1st Department of Internal Medicine, University of Athens, Laikon General Hospital, Athens, Greece
The Christie NHS Foundation Trust, Manchester, UK
Hôpitaux Universitaire Henri Mondor, Créteil, France
Churchill Hospital, Oxford, UK
Karolinska University Hospital Huddinge, Stockholm, Sweden
Rigshospitalet, Copenhagen, Denmark
St. James’s University Hospital, Leeds, UK
Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
Charles University Hospital, Praha, Czech Republic
Charles University Hospital, Praha, Czech Republic
Catholic University Sacred Heart, Rome, Italy
Department of Internal Medicine III, Ulm University, Germany
University Hospital Hradec Kralove, Czech Republic
Department of Onco-Hematology, University Vita-Salute San Raffaele and Scientific Institut San Raffaele, Milano, Italy
Hôpital Avicenne, Bobigny, France
Hematology, Medical University of Vienna, Austria
G. Papanicolaou Hospital, Thessaloniki, Greece
G. Papanicolaou Hospital, Thessaloniki, Greece
Hematology, Trafford General Hospital, Manchester, UK
Groupe Hospitalier Pitié Salpêtrière, Paris, France
Groupe Hospitalier Pitié Salpêtrière, Paris, France
Hospital General de Albacete, Albacete, Spain
Hospital General de Albacete, Albacete, Spain
Policlinico di Modena, Italy
IRST Meldola, Italy
Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
ULSS 18-Rovigo Ospedale “S.Maria della Misericordia’, Rovigo, Italy
Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
Karolinska University Hospital Huddinge, Stockholm, Sweden
dACRO Research & Education Group, University of Glasgow, UK
Hematology, Hospital Clínic, Barcelona, Spain
Vol. 100 No. 4 (2015): April, 2015 https://doi.org/10.3324/haematol.2014.118158